You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Mononucleosis Diagnostic Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Mononucleosis (infection) is an acute, self-limited Infectious disease caused by EBV (a contagious virus, Epstein-Barr) . The clinical features were fever, Laryngitis, Hepatosplenomegaly, abnormal blood lymphocyte, abnormal lymphocyte, positive hetero-agglutination test and anti-EBV antibody in Vivo after infection. Adolescents and young adults (12 to 40 years old) are more likely to be affected.
Market Analysis and Insights: Global Mononucleosis Diagnostic Market
The global Mononucleosis Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mononucleosis Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mononucleosis Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mononucleosis Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mononucleosis Diagnostic market.
Mononucleosis Diagnostic Breakdown Data by Type
Monospot Test
Complete Blood Count Test
Epstein Barr Virus (EBV) Antibody Test
Mononucleosis Diagnostic Breakdown Data by Application
Based on regional and country-level analysis, the Mononucleosis Diagnostic market has been segmented as follows:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Mononucleosis Diagnostic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Cardinal Health
Meridian Bioscience
Quidel Corporation
Sekisui Diagnostics
Thermo Fischer Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mononucleosis Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monospot Test
1.2.3 Complete Blood Count Test
1.2.4 Epstein Barr Virus (EBV) Antibody Test
1.3 Market by Application
1.3.1 Global Mononucleosis Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mononucleosis Diagnostic Market Perspective (2016-2027)
2.2 Mononucleosis Diagnostic Growth Trends by Regions
2.2.1 Mononucleosis Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mononucleosis Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Mononucleosis Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Mononucleosis Diagnostic Industry Dynamic
2.3.1 Mononucleosis Diagnostic Market Trends
2.3.2 Mononucleosis Diagnostic Market Drivers
2.3.3 Mononucleosis Diagnostic Market Challenges
2.3.4 Mononucleosis Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mononucleosis Diagnostic Players by Revenue
3.1.1 Global Top Mononucleosis Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Mononucleosis Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Mononucleosis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mononucleosis Diagnostic Revenue
3.4 Global Mononucleosis Diagnostic Market Concentration Ratio
3.4.1 Global Mononucleosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mononucleosis Diagnostic Revenue in 2020
3.5 Mononucleosis Diagnostic Key Players Head office and Area Served
3.6 Key Players Mononucleosis Diagnostic Product Solution and Service
3.7 Date of Enter into Mononucleosis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mononucleosis Diagnostic Breakdown Data by Type
4.1 Global Mononucleosis Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Mononucleosis Diagnostic Forecasted Market Size by Type (2022-2027)

5 Mononucleosis Diagnostic Breakdown Data by Application
5.1 Global Mononucleosis Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Mononucleosis Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mononucleosis Diagnostic Market Size (2016-2027)
6.2 North America Mononucleosis Diagnostic Market Size by Type
6.2.1 North America Mononucleosis Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Mononucleosis Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Mononucleosis Diagnostic Market Size by Type (2016-2027)
6.3 North America Mononucleosis Diagnostic Market Size by Application
6.3.1 North America Mononucleosis Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Mononucleosis Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Mononucleosis Diagnostic Market Size by Application (2016-2027)
6.4 North America Mononucleosis Diagnostic Market Size by Country
6.4.1 North America Mononucleosis Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Mononucleosis Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Mononucleosis Diagnostic Market Size (2016-2027)
7.2 Europe Mononucleosis Diagnostic Market Size by Type
7.2.1 Europe Mononucleosis Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Mononucleosis Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Mononucleosis Diagnostic Market Size by Type (2016-2027)
7.3 Europe Mononucleosis Diagnostic Market Size by Application
7.3.1 Europe Mononucleosis Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Mononucleosis Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Mononucleosis Diagnostic Market Size by Application (2016-2027)
7.4 Europe Mononucleosis Diagnostic Market Size by Country
7.4.1 Europe Mononucleosis Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Mononucleosis Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mononucleosis Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Type
8.2.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Mononucleosis Diagnostic Market Size by Application
8.3.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Mononucleosis Diagnostic Market Size by Region
8.4.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mononucleosis Diagnostic Market Size (2016-2027)
9.2 Latin America Mononucleosis Diagnostic Market Size by Type
9.2.1 Latin America Mononucleosis Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Mononucleosis Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Mononucleosis Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Mononucleosis Diagnostic Market Size by Application
9.3.1 Latin America Mononucleosis Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Mononucleosis Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Mononucleosis Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Mononucleosis Diagnostic Market Size by Country
9.4.1 Latin America Mononucleosis Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Mononucleosis Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mononucleosis Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type
10.2.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Application
10.3.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Mononucleosis Diagnostic Market Size by Country
10.4.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Mononucleosis Diagnostic Introduction
11.1.4 Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 ELITechGroup
11.2.1 ELITechGroup Company Details
11.2.2 ELITechGroup Business Overview
11.2.3 ELITechGroup Mononucleosis Diagnostic Introduction
11.2.4 ELITechGroup Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.2.5 ELITechGroup Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Details
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Mononucleosis Diagnostic Introduction
11.3.4 Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.3.5 Beckman Coulter Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Mononucleosis Diagnostic Introduction
11.4.4 Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Details
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Mononucleosis Diagnostic Introduction
11.5.4 Cardinal Health Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.5.5 Cardinal Health Recent Development
11.6 Immunostics
11.6.1 Immunostics Company Details
11.6.2 Immunostics Business Overview
11.6.3 Immunostics Mononucleosis Diagnostic Introduction
11.6.4 Immunostics Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.6.5 Immunostics Recent Development
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Details
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Mononucleosis Diagnostic Introduction
11.7.4 Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.7.5 Meridian Bioscience Recent Development
11.8 Quidel Corporation
11.8.1 Quidel Corporation Company Details
11.8.2 Quidel Corporation Business Overview
11.8.3 Quidel Corporation Mononucleosis Diagnostic Introduction
11.8.4 Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.8.5 Quidel Corporation Recent Development
11.9 Sekisui Diagnostics
11.9.1 Sekisui Diagnostics Company Details
11.9.2 Sekisui Diagnostics Business Overview
11.9.3 Sekisui Diagnostics Mononucleosis Diagnostic Introduction
11.9.4 Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.9.5 Sekisui Diagnostics Recent Development
11.10 Thermo Fischer Scientific
11.10.1 Thermo Fischer Scientific Company Details
11.10.2 Thermo Fischer Scientific Business Overview
11.10.3 Thermo Fischer Scientific Mononucleosis Diagnostic Introduction
11.10.4 Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.10.5 Thermo Fischer Scientific Recent Development
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Mononucleosis Diagnostic Introduction
11.11.4 Siemens Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.11.5 Siemens Recent Development
11.12 Biomerieux
11.12.1 Biomerieux Company Details
11.12.2 Biomerieux Business Overview
11.12.3 Biomerieux Mononucleosis Diagnostic Introduction
11.12.4 Biomerieux Revenue in Mononucleosis Diagnostic Business (2016-2021)
11.12.5 Biomerieux Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 130